Edition:
United Kingdom

People: Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

4.89USD
23 Aug 2019
Change (% chg)

$-0.09 (-1.81%)
Prev Close
$4.98
Open
$4.99
Day's High
$4.99
Day's Low
$4.76
Volume
3,451
Avg. Vol
8,546
52-wk High
$10.80
52-wk Low
$4.76

Steele, Michael 

Mr. Michael K. Steele is Vice President - Business Development, Sales and Marketing of Chembio Diagnostics, Inc., Mr. Steele joined Chembio Diagnostic Systems, Inc. in August 2012, and serves as Vice President, Sales/Marketing/Business Development. Prior to joining the company, Mr. Steele served as Vice President, Business Development of Seracare Life Sciences, Inc., a global provider of products and services to in-vitro diagnostic and biopharmaceutical manufacturers. He previously held leadership positions at Serologicals Corporation, Corautus Genetics Inc., and Life Therapeutics Ltd. Mr. Steele received a B.S. in Psychology and a Master of Business Administration from James Madison University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --